CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,192 | +47.0% | 85,274 | +14.3% | 0.00% | – |
| Q2 2023 | $109,637 | -24.6% | 74,583 | 0.0% | 0.00% | – |
| Q1 2023 | $145,436 | +86987.4% | 74,583 | 0.0% | 0.00% | – |
| Q4 2022 | $167 | -99.9% | 74,583 | -0.2% | 0.00% | – |
| Q3 2022 | $180,000 | +16.1% | 74,718 | 0.0% | 0.00% | – |
| Q2 2022 | $155,000 | -23.6% | 74,718 | +3.4% | 0.00% | – |
| Q1 2022 | $203,000 | -15.4% | 72,236 | +40.3% | 0.00% | – |
| Q4 2021 | $240,000 | +72.7% | 51,493 | 0.0% | 0.00% | – |
| Q3 2021 | $139,000 | -4.8% | 51,493 | 0.0% | 0.00% | – |
| Q2 2021 | $146,000 | -6.4% | 51,493 | 0.0% | 0.00% | – |
| Q1 2021 | $156,000 | +3.3% | 51,493 | 0.0% | 0.00% | – |
| Q4 2020 | $151,000 | -8.5% | 51,493 | 0.0% | 0.00% | – |
| Q3 2020 | $165,000 | -4.6% | 51,493 | -1.2% | 0.00% | – |
| Q2 2020 | $173,000 | -1.7% | 52,117 | +7.2% | 0.00% | – |
| Q1 2020 | $176,000 | -64.8% | 48,610 | -50.0% | 0.00% | – |
| Q4 2019 | $500,000 | +73.6% | 97,220 | +100.0% | 0.00% | – |
| Q3 2019 | $288,000 | -6.8% | 48,610 | 0.0% | 0.00% | – |
| Q2 2019 | $309,000 | +9.6% | 48,610 | 0.0% | 0.00% | – |
| Q1 2019 | $282,000 | -53.9% | 48,610 | -50.0% | 0.00% | – |
| Q4 2018 | $612,000 | +120.9% | 97,220 | +100.0% | 0.00% | – |
| Q3 2018 | $277,000 | -6.7% | 48,610 | 0.0% | 0.00% | – |
| Q2 2018 | $297,000 | -8.3% | 48,610 | 0.0% | 0.00% | – |
| Q1 2018 | $324,000 | -10.0% | 48,610 | 0.0% | 0.00% | – |
| Q4 2017 | $360,000 | +5.0% | 48,610 | 0.0% | 0.00% | – |
| Q3 2017 | $343,000 | 0.0% | 48,610 | 0.0% | 0.00% | – |
| Q2 2017 | $343,000 | -5.0% | 48,610 | -6.7% | 0.00% | – |
| Q1 2017 | $361,000 | +35.7% | 52,092 | +7.4% | 0.00% | – |
| Q4 2016 | $266,000 | +10.4% | 48,516 | +0.7% | 0.00% | – |
| Q3 2016 | $241,000 | +11.6% | 48,200 | +0.2% | 0.00% | – |
| Q2 2016 | $216,000 | 0.0% | 48,121 | 0.0% | 0.00% | – |
| Q1 2016 | $216,000 | -14.6% | 48,121 | -0.2% | 0.00% | – |
| Q4 2015 | $253,000 | -8.7% | 48,200 | +0.3% | 0.00% | – |
| Q3 2015 | $277,000 | -19.0% | 48,042 | +0.3% | 0.00% | – |
| Q2 2015 | $342,000 | +7.5% | 47,884 | +0.2% | 0.00% | – |
| Q1 2015 | $318,000 | +11.6% | 47,805 | +0.5% | 0.00% | – |
| Q4 2014 | $285,000 | +22.3% | 47,568 | +0.5% | 0.00% | – |
| Q3 2014 | $233,000 | +20.7% | 47,331 | +9.8% | 0.00% | – |
| Q2 2014 | $193,000 | -0.5% | 43,092 | -0.2% | 0.00% | – |
| Q1 2014 | $194,000 | -11.4% | 43,171 | +0.6% | 0.00% | – |
| Q4 2013 | $219,000 | +12.9% | 42,934 | +0.4% | 0.00% | – |
| Q3 2013 | $194,000 | -11.0% | 42,776 | +0.4% | 0.00% | – |
| Q2 2013 | $218,000 | – | 42,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |